Cargando…
Guidelines on processing and clinical use of skin allografts
Processing methods used for banking of skin for subsequent therapeutic use depend on whether the skin is to retain viability or not. For viable skin grafts, sterilisation techniques cannot be applied, however antibiotics and antimycotics may be used to disinfect the tissue with respect to bacteria a...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125582/ https://www.ncbi.nlm.nih.gov/pubmed/16023931 http://dx.doi.org/10.1016/j.clindermatol.2004.07.018 |
_version_ | 1783515975422836736 |
---|---|
author | Kearney, John N. |
author_facet | Kearney, John N. |
author_sort | Kearney, John N. |
collection | PubMed |
description | Processing methods used for banking of skin for subsequent therapeutic use depend on whether the skin is to retain viability or not. For viable skin grafts, sterilisation techniques cannot be applied, however antibiotics and antimycotics may be used to disinfect the tissue with respect to bacteria and fungi. Nevertheless, strict standards are applied to avoid disease transmission from donor to recipient involving donor medical history, donor testing for viral diseases, aseptic retrieval and processing, and control of storage temperature. Cryopreservation is the preferred method for long term storage of viable skin grafts. If viability is not required, then additional long term preservation methods may be used including deep-freezing, freeze-drying or high concentration solute preservation. All three methods work by reducing water activity. In addition it is possible to apply certain sterilisation techiques that have been shown not to damage the tissue. It is important that sterilisation methods are validated in accordance with precise definitions of sterilisation, and for the initial levels of “bioburden” expected to be present immediately prior to application of the sterilisation method. The application of improved and refined methodologies in accordance with defined standards has ensured improved graft performance while reducing risk to the recipient. |
format | Online Article Text |
id | pubmed-7125582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71255822020-04-08 Guidelines on processing and clinical use of skin allografts Kearney, John N. Clin Dermatol Article Processing methods used for banking of skin for subsequent therapeutic use depend on whether the skin is to retain viability or not. For viable skin grafts, sterilisation techniques cannot be applied, however antibiotics and antimycotics may be used to disinfect the tissue with respect to bacteria and fungi. Nevertheless, strict standards are applied to avoid disease transmission from donor to recipient involving donor medical history, donor testing for viral diseases, aseptic retrieval and processing, and control of storage temperature. Cryopreservation is the preferred method for long term storage of viable skin grafts. If viability is not required, then additional long term preservation methods may be used including deep-freezing, freeze-drying or high concentration solute preservation. All three methods work by reducing water activity. In addition it is possible to apply certain sterilisation techiques that have been shown not to damage the tissue. It is important that sterilisation methods are validated in accordance with precise definitions of sterilisation, and for the initial levels of “bioburden” expected to be present immediately prior to application of the sterilisation method. The application of improved and refined methodologies in accordance with defined standards has ensured improved graft performance while reducing risk to the recipient. Elsevier Inc. 2005 2005-07-15 /pmc/articles/PMC7125582/ /pubmed/16023931 http://dx.doi.org/10.1016/j.clindermatol.2004.07.018 Text en Copyright © 2005 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Kearney, John N. Guidelines on processing and clinical use of skin allografts |
title | Guidelines on processing and clinical use of skin allografts |
title_full | Guidelines on processing and clinical use of skin allografts |
title_fullStr | Guidelines on processing and clinical use of skin allografts |
title_full_unstemmed | Guidelines on processing and clinical use of skin allografts |
title_short | Guidelines on processing and clinical use of skin allografts |
title_sort | guidelines on processing and clinical use of skin allografts |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125582/ https://www.ncbi.nlm.nih.gov/pubmed/16023931 http://dx.doi.org/10.1016/j.clindermatol.2004.07.018 |
work_keys_str_mv | AT kearneyjohnn guidelinesonprocessingandclinicaluseofskinallografts |